Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 17, 2007 10:10 ET | Source: Samaritan Pharmaceuticals, Inc.

Samaritan Pharmaceuticals Begins Trading On OTC Bulletin Board Under Ticker Symbol SPHC

LAS VEGAS, Dec. 17, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals, Inc. (OTCBB:SPHC) (http://www.samaritanpharma.com), a biopharmaceutical company focused on developing innovative therapeutics in...
December 13, 2007 10:23 ET | Source: Samaritan Pharmaceuticals, Inc.

Samaritan Pharmaceuticals to Trade On OTC Bulletin Board

LAS VEGAS, Dec. 13, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals, Inc. (AMEX:LIV) (https://www.samaritanpharma.com), announces that it is seeking to have its common stock trade under a new stock...
December 04, 2007 10:51 ET | Source: Samaritan Pharmaceuticals, Inc.

Samaritan Pharma Retains The Investor Relations Group of New York

LAS VEGAS, Dec. 4, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals, Inc. (AMEX:LIV) (http://www.samaritanpharma.com), a biopharmaceutical company focused on developing innovative therapeutics in...
November 27, 2007 09:23 ET | Source: Samaritan Pharmaceuticals, Inc.

Samaritan Presents Favorable Caprospinol Data At Alzheimer's Drug Development Summit November 30

Conference Showcases the Latest Disease Modifying Therapies and Pre-Symptomatic Approaches for Alzheimer's Drug Development Dr. Lecanu to Present Favorable Caprospinol Data Showing the Clearing ...
November 09, 2007 17:45 ET | Source: Samaritan Pharmaceuticals, Inc.

Samaritan Announces Update on Pharmaplaz Funding

LAS VEGAS, Nov. 9, 2007 (PRIME NEWSWIRE) -- LAS VEGAS November 9, 2007--Samaritan Pharmaceuticals, Inc. (AMEX:LIV) announces that on October 16, 2007, Samaritan announced that it received $8.6 million...
November 08, 2007 10:20 ET | Source: Samaritan Pharmaceuticals, Inc.

Samaritan Expands Revenue Opportunities With Marketing Authorization Approval for HIV Drug Amphocil in Cyprus

LAS VEGAS, Nov. 8, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals, Inc. (AMEX:LIV) is pleased to announce that its subsidiary, Samaritan Pharmaceuticals Europe, S.A., has received notification...
November 06, 2007 10:38 ET | Source: Samaritan Pharmaceuticals, Inc.

Actors Studio's Anna Strasberg Joins Samaritan Advisory Board of Directors

LAS VEGAS, Nov. 6, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc., a developer of innovative drugs (AMEX:LIV), is honored to announce that Ms. Anna Strasberg has joined Samaritan's Advisory...
October 16, 2007 11:31 ET | Source: Samaritan Pharmaceuticals, Inc.

Samaritan Receives $8.6 Million Upfront Payment Under Commercialization Agreement for HIV Drug

LAS VEGAS, Oct. 16, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, announced today that, under a March 9, 2007 agreement with Pharmaplaz, Ltd., a...
October 11, 2007 09:52 ET | Source: Samaritan Pharmaceuticals, Inc.

Three Rivers Adds Territory of Ireland to Samaritan's Existing Exclusive Licensing Agreement to Market Amphocil in Greece and Cyprus

LAS VEGAS, Oct. 11, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative life saving drugs announced today it has signed an exclusive licensing and...
October 08, 2007 09:22 ET | Source: Samaritan Pharmaceuticals, Inc.

Samaritan Highlights Its Most Innovative HIV, Hepatitis C and Alzheimer's Drugs to Partner at Europe's Bio Partnering Conference

LAS VEGAS, Oct. 8, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, announced today its CEO Dr. Janet Greeson will highlight drugs in Samaritan's...